Effect of clofibrate in jaundiced term neonates [7]

Indian Journal of Pediatrics

Volumn 73, Issue 2, 2006, Pages 170-

  Wazir, S ^a   Angiti, R R ^a   Kumar, P ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CLOFIBRATE; CLOFIBRIC ACID; MUSCLE ENZYME; PLACEBO; CHOLAGOGUE;

DOSE RESPONSE; DRUG COST; DRUG EFFECT; DRUG SAFETY; FOLLOW UP; HOSPITALIZATION; HUMAN; HYDRATION; HYPERBILIRUBINEMIA; JAUNDICE; KIDNEY FAILURE; LETTER; LIGHT IRRADIANCE; MEDICAL PRACTICE; MUSCLE ATROPHY; MUSCLE DISEASE; NONHUMAN; PHOTOTHERAPY; NEWBORN; NEWBORN JAUNDICE; NOTE; TERM BIRTH;

CHOLAGOGUES AND CHOLERETICS; CLOFIBRATE; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; PHOTOTHERAPY; TERM BIRTH;

EID: 33746052122     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02820221     Document Type: Letter

References (4)

1. Mohammadzadeh A, Farhat AS, Iranpour R. Effect of clofibrate in jaundiced term newborns. Indian J Pediatr 2005; 72 (2) : 123-126.
2. Bourget P, Broise I, Quinquis-Desmaris V, Gabilan JC. Pharmacokinetics of clofibrate in jaundiced newborn infants at term. Arch Pediatr 1995; 2(8) : 722-728.
3. Rimon D, Ludatscher R, Cohen L. Clofibrate-induced muscular syndrome. Case report with ultrastructural findings and review of the literature. Isr J Med Sci 1984; 20(11) : 1082-1086.
4. Rao MS, Reddy, JK. Hepatocarcinogenesis of peroxisome proliferators. Ann NY Acad Sci 1996; 804 : 573-587.